Both in Pharmaceuticals
Acrivon Therapeutics vs Coya Therapeutics
Over the past year ACRV returned −19.1% and COYA returned −47.4%; their daily moves had a correlation of 0.26.
ACRV −19.1% COYA −47.4%Growth of $1, one year, split-adjusted
| Metric | ACRV | COYA |
|---|---|---|
| Price | $1.74 | $3.08 |
| Market cap | $74.6M | $72.3M |
| Today | +4.19% | −0.96% |
| 1 month | −6.5% | −36.5% |
| 6 months | −16.7% | −27.4% |
| Year to date | −27.8% | −46.9% |
| 1 year | −25.3% | −48.7% |
| Revenue growth (YoY) | — | +49.0% |
| Gross margin | — | 100.0% |
| Net margin | — | −2723.4% |
| P/E (TTM) | — | — |
| Price / sales | — | 9.0× |
| Net cash | $90.0M | $43.2M |
| Dividend yield | — | — |
| Volatility (60d) | 71.1% | 56.9% |
| Short % of float | 7.2% | 7.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).